The Race to Precision Medicine
Free Public Lecture
Ground Floor Auditorium
Peter Doherty Institute
One of the important common goals in the field of health worldwide is to reduce the incidence and mortality of the major chronic non-infectious diseases, such as malignant cancers, cardiovascular diseases, neurodegenerative diseases and diabetes, to improve human health globally. However, conventional medical approaches in both the diagnosis and treatment for those diseases are thought to have reached a ceiling, and have now shown limitations in conquering these health problems.
In recent years, the concept and practice of precision medicine appears to offer hope for providing better medical approaches for health management, clinical diagnosis and treatment in improving quality of life. Development of precision medicine appears able to solve the tough clinical issues, including disease prevention, earlier diagnosis, improving efficacy of targeting drugs, eliminating drug resistance, and prediction of prognosis.
In this lecture, Professor Qimin Zhan will discuss how integrative efforts among biologists, clinicians and genomic scientists, as well as big-data engineers, would be an effective working model in conducting precision medicine for customised health care, including disease prevention, clinical diagnosis and treatment.
Professor Qimin Zhan, President
Professor Qimin Zhan
Peking University Health Science Center
Professor Qimin Zhan is the President of the Peking University Health Science Center, Director of the State Key Laboratory of Molecular Oncology (SKLMO), China, and an Academician of the Chinese Academy of Engineering. His research is focused on molecular pathways involved in the control of cell cycle checkpoint and apoptosis after DNA damage, and the signalling pathways involved in regulation of the maintenance of genomic stability and tumour metastasis. Recently, Professor Zhan has focussed on cancer translational medicine, including molecular diagnosis and personalised therapy.